KATIE BRAUN: Open Payments
NPI 1598303216 · CORALVILLE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 17 payments from 10 companies in 2025. Trend: 2023 $299 · 2024 $150 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $99 |
| PFIZER INC. | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: NURTEC ODT, VRAYLAR, QULIPTA, CAPLYTA, REXULTI, SPRAVATO, Jornay PM, Auvelity.
Industry payments across IA — which companies pay providers there.
